相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Chemotherapy Delivered After Viral Immunogene Therapy Augments Antitumor Efficacy Via Multiple Immune-mediated Mechanisms
Zvi G. Fridlender et al.
MOLECULAR THERAPY (2010)
Transferrin lipoplex-mediated suicide gene therapy of oral squamous cell carcinoma in an immunocompetent murine model and mechanisms involved in the antitumoral response
S. Neves et al.
CANCER GENE THERAPY (2009)
Acute wounds accelerate tumorigenesis by a T cell-dependent mechanism
Christina H. Stuelten et al.
CANCER RESEARCH (2008)
Adenoviral serotypes in gene therapy for esophageal carcinoma
Willem A. Marsman et al.
JOURNAL OF SURGICAL RESEARCH (2007)
Sustained long-term immune responses after in situ gene therapy combined with radiotherapy and hormonal therapy in prostate cancer patients
Tetsuo Fujita et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Biological response determinants in HSV-tk plus ganciclovir gene therapy for prostate cancer
G Ayala et al.
MOLECULAR THERAPY (2006)
Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy
DH Sterman et al.
CLINICAL CANCER RESEARCH (2005)
Virus specific immune responses after human neoadjuvant adenovirus-mediated suicide gene therapy for prostate cancer
RRM van der Linden et al.
EUROPEAN UROLOGY (2005)
Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival
AC Berger et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Neoadjuvant chemoradiotherapy for esophageal carcinoma
X Zhang et al.
DISEASES OF THE ESOPHAGUS (2005)
Ha-RasG12V induces senescence in primary and immortalized human esophageal keratinocytes with p53 dysfunction
M Takaoka et al.
ONCOGENE (2004)
A genetically retargeted adenoviral vector enhances viral transduction in esophageal carcinoma cell lines and primary cultured esophageal resection specimens
CJ Buskens et al.
ANNALS OF SURGERY (2003)
Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing
R Wiewrodt et al.
CANCER GENE THERAPY (2003)
Enhancing antitumor immunity perioperatively - A matter of timing, cooperation, and specificity
JL Curtis et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2003)
Adjuvant immunotherapy for solid tumors: from promise to clinical application
S Mocellin et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
A mouse model of human oral-esophageal cancer
OG Opitz et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Adenovirus-mediated thymidine kinase gene therapy in combination with topotecan for patients with recurrent ovarian cancer: 2.5-year follow-up
A Hasenburg et al.
GYNECOLOGIC ONCOLOGY (2001)
Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapy
BJ Miles et al.
HUMAN GENE THERAPY (2001)
Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma
NG Rainov et al.
CANCER GENE THERAPY (2001)
AV.TK-mediated killing of subcutaneous tumors in situ results in effective immunization against established secondary intracranial tumor deposits
T Okada et al.
GENE THERAPY (2001)
Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy
ES Lambright et al.
GENE THERAPY (2001)
Enhanced therapeutic effect of HSV-tk plus GCV gene therapy and ionizing radiation for prostate cancer
M Chhikara et al.
MOLECULAR THERAPY (2001)
Effect of preexisting anti-herpes immunity on the efficacy of herpes simplex viral therapy in a murine intraperitoneal tumor model
ES Lambright et al.
MOLECULAR THERAPY (2000)
Thymidine kinase gene therapy with concomitant topotecan chemotherapy for recurrent ovarian cancer
A Hasenburg et al.
CANCER GENE THERAPY (2000)
Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with recurrent malignant brain tumors
TW Trask et al.
MOLECULAR THERAPY (2000)
分享论文
